The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
Patients with an indication for initial diagnostic PBR on native kidney
18 ans ≥ Age ≤ 90 ans
Affiliation to french health insurance
Patient having given consent
Kidney transplant patient
Patient on dialysis (hemodialysis or peritoneal dialysis)
Patient under legal protection, guardianship or curatorship
Pregnancy or breastfeeding
7
Trial groupsSee each trial group below.
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Ministry of Health, France
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
National Research Agency, France
Collaborator